MEDVi vs Zepbound: Which Tirzepatide Option Is Actually Worth Your Money in 2026?

MEDVi vs Zepbound — What's the Actual Difference?

This is where most people get confused, so let's clear it up in two sentences.

Zepbound is an FDA-approved brand-name medication. It's tirzepatide made by Eli Lilly, available as pre-filled pens (through insurance/pharmacy) or single-dose vials (through LillyDirect's self-pay program). You need a prescription from your own doctor, and you handle the pharmacy side yourself.

MEDVi is a telehealth membership program. It provides compounded tirzepatide — a pharmacy-prepared formulation made by licensed U.S. compounding pharmacies, not by Eli Lilly, and not FDA-approved — bundled with a doctor evaluation, ongoing clinical support, and home delivery. No insurance needed, no prior authorization, no separate pharmacy visits.

In plain English: Zepbound is the medication. MEDVi is a program that includes the medication. That distinction matters because you're not comparing two identical products. You're comparing two different ways to access the same molecule. The rest of this guide breaks down exactly when each option makes sense. For a deeper look at the molecule itself, see our semaglutide vs tirzepatide comparison.

Quick Decision: Who Should Pick MEDVi, and Who Should Pick Zepbound?

Pick Zepbound if:

• Your insurance covers it. With a Zepbound Savings Card and commercial insurance, you may pay as low as $25/month. That's unbeatable. Check with your insurer first.
• You want FDA-approved medication. Zepbound has been through the full FDA approval process as a finished product. If that distinction matters to you — and for some people it absolutely should — Zepbound is the clear choice.
• You already have a prescribing doctor. If your physician manages your weight-loss treatment and you have an established relationship, adding Zepbound through your existing care team is the most seamless path.
• You prefer auto-injector pens. Zepbound pens are available through insurance and retail pharmacies (at list price). LillyDirect's discounted pricing is for vials only, which require manual syringe injection.

Pick MEDVi if:

• You're paying out of pocket. No insurance coverage for weight-loss drugs? MEDVi's all-inclusive pricing (tirzepatide tablets from $279 first month; injections from $349 first month; around $399/month ongoing per ConsumerAffairs) eliminates the doctor-visit costs, pharmacy markup, and prior authorization headaches that come with pursuing brand-name drugs without coverage. See also: how to get GLP-1 without insurance.
• You want one monthly payment that covers everything. MEDVi bundles the physician evaluation, medication, shipping, metabolic report, and 24/7 messaging support into a single price. No surprise bills.
• You want to start fast. Most MEDVi patients get approved within 24 hours and receive medication within 7–9 days. No scheduling doctor appointments, no waiting for prior authorization responses, no pharmacy stock issues.
• You're comfortable with compounded medication. MEDVi partners with named, licensed pharmacies (Belmar Pharma Solutions and Beluga Health) and is LegitScript certified. More on compounded medication safety below.
• You hate needles. MEDVi offers compounded tirzepatide in dissolvable tablet form — an option Zepbound doesn't have. See our MEDVi pills reviews.

Skip both and talk to your doctor first if:

You take insulin, have a history of pancreatitis, have (or have family history of) medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, are pregnant or planning to become pregnant, or have severe gastrointestinal disease. Tirzepatide — in any form — may not be appropriate for you, and a thorough medical evaluation is essential before starting. Learn more in our GLP-1 eligibility guide.

MEDVi vs Zepbound Comparison Table

(Verified February 16, 2026. Zepbound pricing: LillyDirect.lilly.com + official terms. MEDVi pricing/policies: ConsumerAffairs.com/health/medvi.html + MEDVi.org refund policy page. Prices and policies subject to change — always confirm directly before purchasing.)

How Much Does MEDVi Cost vs Zepbound? (Real Numbers, Not “It Depends”)

Cost is the #1 reason you're on this page. So let's get specific. For a broader view of GLP-1 pricing, see our GLP-1 cost breakdown and cheapest GLP-1 without insurance guides.

MEDVi Pricing: What You Actually Pay

MEDVi operates on a month-to-month subscription. No long-term contracts. Here's the breakdown based on ConsumerAffairs reporting and MEDVi's own policy pages:

Compounded tirzepatide injections:

• First month: from $349 (per MEDVi's refund policy page)
• Ongoing monthly: approximately $399 (per ConsumerAffairs)

Compounded tirzepatide tablets (dissolvable):

• First month: $279 (per MEDVi's refund policy page)
• Ongoing monthly: confirm directly with MEDVi before enrolling, as pricing varies by formulation and dose

What's included in every payment:

• Licensed physician evaluation (through OpenLoop Health network)
• Personalized treatment plan and metabolic report
• Full month of medication
• Standard shipping with cold packs
• Unlimited messaging with clinical team
• 24/7 support access

What's NOT included:

• Lab work (only required if your medical history warrants it — MEDVi states lab work may be included depending on clinical need; details can vary)

Annual cost estimate: Roughly $4,500–$5,500 for a full year, depending on your formulation and dose trajectory. Most patients start at the lower end and increase over time.

Zepbound Pricing: Three Very Different Paths

The price you pay for Zepbound depends entirely on your insurance situation. There are three lanes:

Lane 1: Insurance + Savings Card (best case)

If you have commercial insurance that covers Zepbound, you can apply for the Zepbound Savings Card and potentially pay as low as $25/month. Savings are capped at up to $100 per 1-month fill (Lilly defines “month” as 28 days), $200 per 2-month fill, or $300 per 3-month fill, with a $1,300 annual maximum. The card is valid through December 31, 2026. Government insurance (Medicare, Medicaid, TRICARE, VA) is excluded from the Savings Card.

Lane 2: LillyDirect Self-Pay Vials (no insurance needed)

As of December 1, 2025, Eli Lilly reduced cash prices on LillyDirect:

These are single-dose vials that require manual injection with a syringe (not auto-injector pens). You need a valid prescription from your own doctor.

Lane 3: Retail/List Price (worst case)

Without LillyDirect, insurance, or any savings program, Zepbound's list price is approximately $1,086/month regardless of dose. This is what you'd pay at most retail pharmacies without coverage.

The 12-Month Math

Here's what a full year actually looks like at common scenarios:

The takeaway: If your insurance covers Zepbound, take Zepbound. Nothing else comes close to that price. If you're paying cash, MEDVi and LillyDirect land in a similar range — but MEDVi includes the doctor, support, and shipping. LillyDirect is medication only, and you need to bring your own prescription. For more cost comparisons, see our cheapest semaglutide guide.

Is MEDVi Legit? (How to Verify It Yourself)

Let's address the elephant in the room. If you've been Googling “is MEDVi legit” or “MEDVi scam,” you're not paranoid — you're smart. The online weight-loss space has real problems, and the FDA has flagged specific concerns about unapproved GLP-1 products being sold online. For more detail, see our MEDVi tirzepatide reviews.

Here's what we verified about MEDVi:

Your verification checklist for any online GLP-1 program.

*Illustration only. Safety verification steps for educational purposes. Actual medication packaging and appearance may vary.*

Your Verification Checklist (Before You Start Any Online GLP-1 Program)

This isn't just for MEDVi — use this for any telehealth weight-loss program you consider. It's built from the FDA's published guidance on unapproved GLP-1 drugs:

Based on our verification, MEDVi meets every item on this checklist as of February 2026. That doesn't mean it's for everyone — but it does mean it appears to be operating within legitimate medical and pharmaceutical frameworks. Conditions can change; always re-verify before enrolling. For more context, see our best GLP-1 online programs guide and MEDVi vs Ozempic comparison.

Compounded Tirzepatide vs Zepbound: What's the Safety Difference?

This is the most important section on this page. Don't skip it.

What “FDA-Approved” Actually Means

Zepbound is an FDA-approved finished product. That means Eli Lilly submitted extensive clinical trial data proving it's safe and effective, and the FDA reviewed and approved its manufacturing process, labeling, and quality controls.

MEDVi's compounded tirzepatide uses the same active pharmaceutical ingredient — tirzepatide — but it's prepared by compounding pharmacies, not Eli Lilly's manufacturing facilities. Compounded medications are legal and regulated, but they haven't gone through the same pre-market approval process as brand-name drugs. The FDA does not verify compounded products for safety, effectiveness, or quality the same way it does for approved medications. For more, see our is compounded GLP-1 safe? guide.

This is a real distinction, not marketing language. It's the single most important trade-off in this entire comparison.

The FDA's Specific Concerns (And What They Mean for You)

The FDA has a dedicated page outlining its concerns about unapproved GLP-1 drugs used for weight loss. Here's what they flag and how it applies:

The Calm, Non-Alarmist Conclusion

Compounded medication isn't automatically “bad.” Compounding pharmacies have been a legitimate part of American healthcare for decades — they exist because patients sometimes need medications in forms or doses that manufacturers don't offer. Read more in our best compounded semaglutide guide.

But compounded medication does demand more vigilance from you. If you choose MEDVi, use the checklist above. Verify the pharmacy. Inspect your shipment. Report anything unusual to your provider.

If FDA approval is an absolute requirement for your peace of mind, choose Zepbound. That's a perfectly valid decision and you shouldn't let anyone talk you out of it. If you're comfortable with a licensed, LegitScript-certified program that uses named U.S. compounding pharmacies and real physicians, MEDVi is a credible option that over 100,000 patients have used (per MEDVi.org).

Does Tirzepatide Work the Same in MEDVi as in Zepbound?

What the Clinical Evidence Shows

The active ingredient in both Zepbound and MEDVi's compounded version is tirzepatide — a dual GIP/GLP-1 receptor agonist. Here's what large-scale clinical trials found:

SURMOUNT-1 (published in the New England Journal of Medicine, 2022; 2,539 participants over 72 weeks):

Numbers below are from Zepbound's FDA-approved prescribing information (treatment-regimen estimand):

To put that in perspective: at the highest dose, more than half of participants lost over 20% of their body weight. About nine out of ten lost at least 5%.

SURMOUNT-5 (published in NEJM, 2025; tirzepatide vs semaglutide head-to-head): Tirzepatide achieved 20.2% average weight loss compared to 13.7% for semaglutide (the active ingredient in Ozempic and Wegovy). Tirzepatide was superior at every weight-loss threshold measured. For more on this comparison, see our semaglutide vs tirzepatide deep dive.

Clinical trial results for tirzepatide weight loss outcomes.

*Illustration only. Clinical data visualization for educational purposes. Actual medication packaging and appearance may vary.*

What We Can Say — And What We Can't

These trials used Eli Lilly's manufactured tirzepatide, not compounded versions. We can say with confidence that tirzepatide as an active ingredient produces significant weight loss in clinical settings.

We cannot say that compounded tirzepatide from any specific pharmacy will produce identical results. Compounded products haven't been through the same clinical trials. That said, when a licensed pharmacy uses the correct active ingredient at the correct dose and concentration, the mechanism of action is the same.

Practical Expectations (Not Hype)

If you start tirzepatide through either MEDVi or Zepbound, here's what a realistic timeline looks like:

What “food noise” actually means. This is the term patients use to describe the constant background chatter about food — what to eat next, cravings, fixation on snacks, difficulty stopping once you start. Tirzepatide significantly reduces this. In patient reports, the reduction in food noise is often the most impactful change people notice — even more than the number on the scale.

The non-negotiables: Tirzepatide isn't magic. The clinical trials included a reduced-calorie diet (500 calorie daily deficit) and at least 150 minutes of physical activity per week as part of the protocol. Protein intake matters — especially on a GLP-1, where muscle preservation requires adequate protein (most providers recommend roughly 0.7–1 gram per pound of target body weight daily). Movement, sleep, and hydration all play a role. For dietary guidance, see our what to eat on GLP-1 guide and GLP-1 SOS guide.

The plateau is normal. Every person who takes tirzepatide long enough will eventually reach a weight-loss plateau. Research from the SURMOUNT trials confirmed this is a physiological phase, not a failure. Your body adjusts its energy expenditure as you lose weight. Most patients plateau somewhere between months 9 and 18 depending on their dose and starting weight. When it happens, it doesn't mean the drug stopped working — it means your body found a new equilibrium. Read more in our what happens when you stop GLP-1 article.

Side Effects: What's Different (and What's the Same)

Since both Zepbound and MEDVi's compounded version deliver tirzepatide, the side effect profile is largely the same. Here's what to expect based on Zepbound's FDA-approved prescribing information:

Common Side Effects (Most Are Temporary)

These happen most often during the first few weeks and during dose increases. They usually improve as your body adjusts:

• Nausea (the most common — reported by roughly 1 in 4 users at higher doses)
• Diarrhea
• Constipation
• Stomach pain
• Vomiting
• Indigestion/heartburn
• Fatigue
• Injection site reactions (for injectable forms)
• Hair loss (typically temporary)
• Belching

Most of these are GI-related and happen because tirzepatide slows gastric emptying — your stomach processes food more slowly. Starting at a low dose and increasing gradually (titration) helps minimize these effects, which is exactly what both Zepbound and MEDVi protocols do.

Side effects overview and management strategies for tirzepatide.

*Illustration only. Side effect guidance for educational purposes. Actual medication packaging and appearance may vary.*

Serious Warnings

These are rare but important. Discuss them with your prescribing provider:

• Thyroid C-cell tumors: Tirzepatide caused thyroid tumors in animal studies. It's unknown if this occurs in humans. Do NOT use tirzepatide if you or a family member have had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Pancreatitis: Stop use and contact your provider immediately if you experience severe abdominal pain that doesn't go away.
• Gallbladder problems: Including gallstones.
• Hypoglycemia: Especially if combined with insulin or sulfonylureas.
• Kidney injury: Severe GI side effects (vomiting, diarrhea) can cause dehydration, which can stress the kidneys.
• Serious allergic reactions: Difficulty breathing, swelling, rapid heartbeat.
• Vision changes in patients with type 2 diabetes.
• Depression or suicidal thoughts: Rare, but report any mood changes to your provider.

What to Do if Side Effects Hit

Don't panic. Do communicate. Contact your prescribing provider about any side effects — that's what they're there for. MEDVi offers 24/7 messaging with your clinical team, which makes reporting side effects faster than waiting for a doctor's office to open.

General comfort measures: Stay hydrated. Eat smaller meals. Increase fiber gradually. Avoid fatty or greasy foods during dose escalation. These aren't medical prescriptions — they're practical tips that most patients find helpful. For detailed dietary guidance, see our GLP-1 nausea relief guide.

When to seek urgent care: Severe abdominal pain that doesn't go away, signs of allergic reaction (swelling of face/throat, difficulty breathing), or persistent vomiting/diarrhea causing dehydration.

The One Honest Downside to MEDVi That Most Review Sites Won't Tell You

Every comparison page makes MEDVi sound effortless. Let's be real about one thing.

MEDVi's billing cycle starts when you sign up — not when your medication arrives. Because physician review, pharmacy processing, and shipping can take 7–9 days, your first billing cycle is already running before you have medication in hand. If you're not expecting this, it feels like you're paying for days you didn't use.

It's not a scam. It's how most subscription telehealth programs work. But nobody explains it upfront, and it catches people off guard.

The fix is simple: Understand the timeline before you enroll. Your first month includes the physician evaluation, treatment plan, metabolic report, and the medication itself. Think of it as an onboarding period. After month one, refills align more closely with a 30-day cycle.

Here's what matters more than the billing timing: MEDVi has no long-term contracts. You can cancel anytime with 72 hours' notice before your next billing date. There's no cancelation fee. And if the program doesn't work — they put their money where their mouth is with a money-back guarantee: follow the program for five months, demonstrate you haven't lost weight, and you'll receive a 75% refund.

That's more accountability than Zepbound, LillyDirect, or any retail pharmacy offers. Zepbound is a medication, not a program — there's no guarantee, no refund, and no support beyond what your own doctor provides. Over 100,000 patients have used MEDVi (per their homepage as of Feb 2026). The program holds approximately a 4.5-star rating on Trustpilot. Are there some billing complaints? Yes — and MEDVi responds to nearly all negative reviews publicly. Transparency under criticism is, honestly, a better trust signal than a perfect score.

What Real Patients Are Saying: MEDVi Reviews and Zepbound Experiences

We pulled these from third-party review platforms — not MEDVi's marketing materials.

How to Read Online Reviews Intelligently

For a deeper look at MEDVi patient experiences, see our MEDVi tirzepatide reviews page.

How Does MEDVi Work from Signup to First Shipment?

Here's the step-by-step, based on ConsumerAffairs reporting and our own research:

State Availability

MEDVi is available in 49 states — every state except North Dakota. Some states may have specific requirements (such as an initial provider visit or restrictions on tablet vs. injection prescriptions). Confirm your state's requirements during the evaluation process.

How Do You Actually Get Zepbound? (Step-by-Step)

Insurance Route

1. Visit your doctor and discuss tirzepatide for weight loss.
2. Your doctor submits a prior authorization to your insurance company (if required).
3. Wait for approval. This can take days to weeks. Many patients get denied on the first attempt.
4. If denied, appeal. Your doctor can submit additional documentation. Some patients go through multiple rounds.
5. If approved, fill at your pharmacy. Apply the Zepbound Savings Card if eligible.

LillyDirect Self-Pay Route

1. Get a prescription from your doctor (any licensed prescriber authorized to prescribe in your state can write it).
2. Visit LillyDirect (zepbound.lilly.com) and create an account.
3. Select single-dose vials at the discounted pricing ($299–$449/month depending on dose).
4. Enroll in the Self Pay Journey Program to lock in program pricing.
5. Medication ships to your door or is available for Walmart pharmacy pickup in select locations.
6. Refill within 45 days to maintain program pricing at doses of 7.5 mg and above.

What Slows People Down

• No primary care doctor: You need a prescriber to use LillyDirect. If you don't have one, you'll need to find a doctor who can write a tirzepatide prescription — which takes time.
• Prior authorization delays: Insurance companies routinely deny first requests for weight-loss medications.
• Pharmacy stock issues: Zepbound has experienced intermittent supply constraints.
• The vial learning curve: LillyDirect vials require drawing medication with a syringe. If you've never self-injected, there's a brief learning period.

LillyDirect Vials: What You Need to Know About Supplies

LillyDirect's discounted vial pricing ($299–$449/month) covers the medication only. The vials are single-dose — you'll need to draw the medication into a syringe yourself. Supplies you'll need:

• Insulin syringes (typically 1 mL with 29–31 gauge needle)
• Alcohol swabs for injection site preparation
• Sharps container for safe needle disposal

These supplies are inexpensive (roughly $10–$20/month from any pharmacy or Amazon) but they're not included in LillyDirect's price, and Lilly doesn't mention this prominently. MEDVi ships everything you need with your medication — no separate supply purchases required.

Can You Switch Between MEDVi and Zepbound?

Yes. Because both use tirzepatide, switching is pharmacologically straightforward. But there are a few things to know:

• Talk to your provider first. Whether you're going from MEDVi to Zepbound or vice versa, a clinician should help manage the transition to ensure your dose stays consistent.
• Document your dose history. If you've been on 10 mg through MEDVi and switch to Zepbound, your new prescriber needs to know exactly where you are in your titration.
• Don't overlap. Never take doses from two sources simultaneously.
• Allow for timing. If you cancel MEDVi and are transitioning to Zepbound through insurance, there may be a gap while prior authorization processes. Plan ahead.

The molecule is the same. The transition is usually seamless as long as your providers communicate.

Insurance, HSA/FSA, and How People Actually Pay

The practical reality: If you have commercial insurance → check Zepbound coverage first. If you don't have coverage → MEDVi and LillyDirect are your two main cash-pay paths, and the right choice depends on whether you want a full program or just the medication. For more options, see our how to get GLP-1 without insurance guide.

The One Honest Downside to Zepbound That Most People Miss

We covered MEDVi's billing quirk above. Here's the Zepbound one:

LillyDirect's 45-day refill window is unforgiving at higher doses. At 7.5 mg and above, if you don't reorder within 45 days of your last delivery, your price jumps to the standard self-pay rate:

• 7.5 mg: $449 → $599
• 10 mg: $449 → $699
• 12.5 mg: $449 → $849
• 15 mg: $449 → $1,049

You can re-enroll in the Self Pay Journey Program with your next order to get back to $449 — but that one missed refill will cost you. Life happens. Vacations happen. A busy week happens. That refill window is tighter than it looks. MEDVi doesn't have this refill-window penalty — your subscription price doesn't spike if you reorder a few days late.

If You're Still Undecided: The 60-Second Decision Rule

Ask yourself three questions:

That's it. Three questions, clear answer.

Frequently Asked Questions

Edge Cases and Scenarios Most Guides Don't Cover

I was denied by insurance. Now what?

Start by appealing — your doctor can submit additional clinical documentation, and many patients get approved on appeal. While you wait, LillyDirect's self-pay vials or MEDVi's compounded tirzepatide are options that don't require insurance approval. Some patients use a hybrid approach: start on MEDVi or LillyDirect while their insurance appeal processes, then switch to insurance coverage if approved.

I'm on a different GLP-1 (Ozempic/Wegovy). Can I switch to tirzepatide?

Yes, with your provider's guidance. Many patients who plateau on semaglutide switch to tirzepatide for the additional GIP receptor activation. Head-to-head data (SURMOUNT-5) supports tirzepatide's superiority in terms of weight loss. Your provider will help manage the transition, typically starting tirzepatide at a lower dose to minimize GI side effects even if you were on a higher dose of semaglutide. For more on this, see our semaglutide vs tirzepatide comparison.

What about the TrumpRx program I keep hearing about?

TrumpRx.gov launched on February 5, 2026 as a federal discount/coupon platform that directs patients to drugmakers' direct-to-consumer websites. Zepbound is listed, with monthly pricing as low as $299 depending on dose — similar to LillyDirect pricing. TrumpRx is for cash-paying patients only (discounts don't apply through insurance). It doesn't sell medications directly — it aggregates manufacturer coupons and links. Availability and pricing can change; check TrumpRx.gov for current details.

I'm over 65. Is tirzepatide safe for me?

Age alone doesn't disqualify you. The SURMOUNT trials included participants across a range of ages. However, older adults may face additional considerations: risk of muscle loss is higher (protein intake becomes even more important), and drug interactions are more likely with multiple medications. Get a thorough medical evaluation — MEDVi's physicians screen for these factors, and your own doctor should be involved if you have complex medical needs.

I had bariatric surgery. Can I still use tirzepatide?

This is a conversation for your surgeon and endocrinologist. Some patients who've had gastric bypass or sleeve gastrectomy use GLP-1 medications for weight regain. But the altered GI anatomy can affect absorption and side effects. This is not a decision to make through a telehealth platform alone.

I'm breastfeeding. Can I take tirzepatide?

There is insufficient data on tirzepatide use during breastfeeding. The FDA labeling recommends discussing benefits and risks with your healthcare provider. Most obesity medicine specialists advise waiting until after breastfeeding to start GLP-1 treatment.

What happens to my loose skin after significant weight loss?

This isn't a tirzepatide-specific concern, but it's real. With 20%+ weight loss, many patients experience excess skin, particularly around the abdomen, arms, and thighs. The degree depends on your age, genetics, how much weight you lose, and how quickly. Some patients pursue skin removal surgery after reaching their goal weight (typically waiting 12–18 months at a stable weight). Insurance coverage for excess skin removal varies.

How We Evaluated MEDVi vs Zepbound (Our Methodology)

What to Expect in Your First Month (Whichever You Choose)

Starting tirzepatide is a real commitment — financially, physically, and mentally. Here's an honest preview so there are no surprises.

Bottom Line: Your Next Step

You've read the data. Here's what to do with it.

Tirzepatide works. The clinical data is as strong as it gets in obesity medicine. The only question is which path gets it into your hands safely, affordably, and sustainably.

Whatever you choose — talk to a qualified healthcare provider and make sure this medication is appropriate for your specific health situation. This guide is informational, not medical advice.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Weight Loss Provider Guide is an independent review site. We may earn a commission from purchases through our links, which helps fund our research. Read our editorial standards and medical reviewer information.

Full medical disclaimer · Advertising disclosure · Learn more about GLP-1s

Sources

1. Jastreboff AM, Aronne LJ, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine. 2022;387:205-216.
2. Aronne LJ, Bade Horn D, et al. “Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.” New England Journal of Medicine. 2025;393(1).
3. Eli Lilly and Company. “Zepbound Single-Dose Vials at Lower Prices on LillyDirect.” Investor.lilly.com. December 1, 2025.
4. U.S. Food and Drug Administration. “FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” FDA.gov. Updated 2025.
5. Zepbound (tirzepatide) Full Prescribing Information. Eli Lilly and Company. pi.lilly.com.
6. ConsumerAffairs. “MEDVi Review.” ConsumerAffairs.com. Updated February 2026.
7. Reuters. “Eli Lilly Cuts Zepbound Price to Widen Access to Obesity Drug.” Reuters.com. December 1, 2025.